At Yale New Haven Health, we’re delivering pioneering research from Yale School of Medicine to improve people’s lives every single day.
Dr. Eric Velazquez spearheaded clinical research that has redefined international guidelines for heart failure treatment.
Drs. Erica Spatz and Samit Shah helped advance a procedure that detects coronary microvascular disease that’s often misdiagnosed in women.
Dr. Kiran Turaga, a thought leader in novel treatments of cancer, applies heated, concentrated chemotherapy, called Hyperthermic intraperitoneal chemotherapy (HIPEC), to treat Stage IV cancer cells like never before.
Dr. Kevan Herold led teams of colleagues across the U.S. to develop a game-changing drug that can delay the onset of type 1 diabetes for years.
Dr. Roy Herbst, an international leader in innovative research and clinical trials has advanced the use of immunotherapy and targeted therapies to personalize treatment for lung cancer.
Dr. Mert Bahtiyar’s multidisciplinary team performs in utero surgery to successfully treat spina bifida before birth.
Yale New Haven Hospital Nationally Ranked by U.S. News & World Report
